Ebola Virus Disease: A New Challenge in Peacekeeping Missions, Medical Practices, and Preventive Measures for the Thai Horizontal Military Engineering Company in South Sudan
Main Article Content
Abstract
The United Nations Mission in South Sudan (UNMISS) peacekeeping operations by the Thai Horizontal Military Engineering Company (Thai HMEC) are facing a non-traditional security threat from the resurgence of Ebola Virus Disease (EVD) in Africa. In May 2026, the World Health Organization (WHO) declared the outbreak of Bundibugyo ebolavirus in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern (PHEIC). Consequently, South Sudan faces high epidemiological vulnerability due to its shared borders with the affected regions. A major clinical challenge of this crisis is that the Bundibugyo strain currently lacks approved targeted vaccines or definitive therapies, making outbreak control entirely dependent on strict patient isolation and preventive medicine strategies.
In response, the Level 1 Hospital of the Thai HMEC (Rotation 6) has elevated its health surveillance and early detection protocols. Comprehensive infection prevention and control (IPC) practices have been stringently enforced, including mandatory hand hygiene campaigns and the installation of alcohol gel stations across the unit. Concurrently, isolation facilities have been prepared, personal protective equipment (PPE) stockpiles verified, and continuous biosecurity training provided to medical staff and troops. Although no EVD cases have been reported within South Sudan to date, these systematic medical preparedness and health security reinforcement measures are vital to mitigate infection risks, sustain operational readiness, and ensure the safety of Thai peacekeepers.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the Royal Thai Army Medical Department and published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.
Use or modification of the articles is prohibited without permission.
Statements expressed in the articles are solely the opinions of the authors.
Authors are fully responsible for the content and accuracy of their articles.
Any other republication of the articles requires permission from the journal.
References
Feldmann H, Sprecher A, Geisbert TW. Ebola. N Engl J Med. 2020;382(19):1832-42. doi:10.1056/NEJMra1901594.
Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, Ansari AA, et al. Ebola virus disease: an emerging and re-emerging viral threat. J Autoimmun. 2020;106:102375. doi:10.1016/j.jaut.2019.102375.
Letafati A, Salahi Ardekani O, Karami H, Soleimani M. Ebola virus disease: a narrative review. Microb Pathog. 2023;181:106213. doi:10.1016/j.micpath.2023.106213.
Jain S, Martynova E, Rizvanov A, Khaiboullina S, Baranwal M. Structural and functional aspects of Ebola virus proteins. Pathogens. 2021;10(10):1330. doi:10.3390/pathogens10101330.
World Health Organization. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Jun 7]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON602
Centers for Disease Control and Prevention. Ebola outbreak: current situation [Internet]. Atlanta (GA): U.S. Department of Health and Human Services; 2026 [cited 2026 Jun 18]. Available from: https://www.cdc.gov/ebola/situation-summary/index.html
Furuyama W, Marzi A. Ebola virus: pathogenesis and countermeasure development. Annu Rev Virol. 2019;6(1):435-58. doi:10.1146/annurev-virology-092818-015708.
Kajihara M, Hang’ombe BM, Changula K, Harima H, Isono M, Okuya K, et al. Marburgvirus in Egyptian fruit bats, Zambia. Emerg Infect Dis. 2019;25(8):1577-80. doi:10.3201/eid2508.190268.
Kennedy JR. Phosphatidylserine’s role in Ebola’s inflammatory cytokine storm and hemorrhagic consumptive coagulopathy and the therapeutic potential of annexin V. Med Hypotheses. 2020;135:109462. doi:10.1016/j.mehy.2019.109462.
Fischer WA, Brown J, Wohl DA, Loftis AJ, Tozay S, Reeves E, et al. Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute Ebola virus infection. Open Forum Infect Dis. 2017;4(3). doi:10.1093/ofid/ofx155.
Bettini A, Lapa D, Garbuglia AR. Diagnostics of Ebola virus. Front Public Health. 2023;11:1123024. doi:10.3389/fpubh.2023.1123024.
Land KJ, Boeras DI, Chen XS, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol. 2019;4(1):46-54. doi:10.1038/s41564-018-0295-3.
Keshtkar-Jahromi M, Martins KAO, Cardile AP, Reisler RB, Christopher GW, Bavari S. Treatmentfocused Ebola trials, supportive care and future of filovirus care. Expert Rev Anti Infect Ther. 2018;16(1):67-76. doi:10.1080/14787210.2018.1413937.
Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293-303. doi:10.1056/NEJMoa1910993.
Tomori O, Kolawole MO. Ebola virus disease: current vaccine solutions. Curr Opin Immunol. 2021;71:27-33. doi:10.1016/j.coi.2021.03.008.
World Health Organization. WHO list of personal protective equipment for infection prevention and control with focus on Ebola classified by donation priority [Internet]. Geneva: World Health Organization; 2015 [cited 2026 Jun 17]. Available from: https://www.who.int/publications/m/item/ppe_list_31mar2015
Kening MZ, Groen K. Personal protective equipment. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2026 Jun 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK589639/
World Health Organization. Epidemic of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Jun 7]. Available from: https://www.who.int/news/item/17-05-2026-epidemic-of-ebola-disease-in-thedemocratic-republic-of-the-congo-and-uganda-determined-a-public-health-emergency-ofinternational-concern
UK Health Security Agency. Outbreaks under monitoring: week 24, week ending 14 June 2026 [Internet]. London: UK Health Security Agency; 2026 [cited 2026 Jun 18]. Available from: https://www.gov.uk/government/publications/outbreaks-under-monitoring-in-2026/outbreaksunder-monitoring-week-24-week-ending-14-june-2026
United Nations Mission in South Sudan, Force Headquarters. Fragmentary order (FRAGO) 06 to Operation Order (OPORD) 01-26: response to Ebola, FORCE CONPLAN 02/18. Juba: United Nations; 2026.